𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Comparative study of the immunogenicity and safety of two doses of recombinant hepatitis B vaccine in healthy adolescents

✍ Scribed by Gilbert M. Schiff; James R. Sherwood; Jerome B. Zeldis; David S. Krause

Book ID
116173325
Publisher
Elsevier Science
Year
1995
Tongue
English
Weight
394 KB
Volume
16
Category
Article
ISSN
1054-139X

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou πŸ“‚ Article πŸ“… 1985 πŸ› John Wiley and Sons 🌐 English βš– 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.

Recombinant-yeast-derived hepatitis b va
Recombinant-yeast-derived hepatitis b vaccine in healthy adults: Safety and two-year immunogenicity of early investigative lots of vaccine
✍ Lynn Butterly; Eloise Watkins; Jules L. Dienstag πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 554 KB

We tested the safety and long-term immunogenicity of two of the early investigative lots of a recombinant-yeast-derived hepatitis B vaccine in immunocompetent adults. Three 10-micrograms doses of recombinant hepatitis B vaccine (Merck Sharp & Dohme Research Laboratories, West Point, PA) were adminis